These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 9823469)
41. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170 [TBL] [Abstract][Full Text] [Related]
42. Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Yang SZ; Kohno N; Kondo K; Yokoyama A; Hamada H; Hiwada K; Miyake M Int J Oncol; 1999 Dec; 15(6):1109-15. PubMed ID: 10568816 [TBL] [Abstract][Full Text] [Related]
43. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer. de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524 [TBL] [Abstract][Full Text] [Related]
44. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305 [TBL] [Abstract][Full Text] [Related]
45. Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis. Tucker E; Buda A; Janghra B; Cpoad J; Moorghan M; Havler M; Dettmar P; Pignatelli M Proc Nutr Soc; 2003 Feb; 62(1):229-36. PubMed ID: 12756972 [TBL] [Abstract][Full Text] [Related]
46. Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Nawrocki B; Polette M; Van Hengel J; Tournier JM; Van Roy F; Birembault P Am J Pathol; 1998 Nov; 153(5):1521-30. PubMed ID: 9811344 [TBL] [Abstract][Full Text] [Related]
47. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa. Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624 [TBL] [Abstract][Full Text] [Related]
48. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Ramesh S; Nash J; McCulloch PG Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738 [TBL] [Abstract][Full Text] [Related]
49. Characterization of the E-cadherin/catenin complex in colorectal carcinoma cell lines. El-Bahrawy M; Poulsom R; Rowan AJ; Tomlinson IT; Alison MR Int J Exp Pathol; 2004 Apr; 85(2):65-74. PubMed ID: 15154912 [TBL] [Abstract][Full Text] [Related]
50. The cadherin-catenin superfamily in endocrine tumors. Semba S; Yamakawa M; Sasano H Endocr Pathol; 2001; 12(1):1-13. PubMed ID: 11478263 [TBL] [Abstract][Full Text] [Related]
52. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression. Koppert LB; van der Velden AW; van de Wetering M; Abbou M; van den Ouweland AM; Tilanus HW; Wijnhoven BP; Dinjens WN Br J Cancer; 2004 Feb; 90(4):892-9. PubMed ID: 14970870 [TBL] [Abstract][Full Text] [Related]
53. Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas. van der Wurff AA; Vermeulen SJ; van der Linden EP; Mareel MM; Bosman FT; Arends JW J Pathol; 1997 Jul; 182(3):325-30. PubMed ID: 9349236 [TBL] [Abstract][Full Text] [Related]
54. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines. Mialhe A; Levacher G; Champelovier P; Martel V; Serres M; Knudsen K; Seigneurin D J Urol; 2000 Sep; 164(3 Pt 1):826-35. PubMed ID: 10953163 [TBL] [Abstract][Full Text] [Related]
55. Defective E-cadherin/catenin complexes in human cancer. Van Aken E; De Wever O; Correia da Rocha AS; Mareel M Virchows Arch; 2001 Dec; 439(6):725-51. PubMed ID: 11787845 [TBL] [Abstract][Full Text] [Related]
56. Dysregulation of beta-catenin is common in canine sporadic colorectal tumors. McEntee MF; Brenneman KA Vet Pathol; 1999 May; 36(3):228-36. PubMed ID: 10332831 [TBL] [Abstract][Full Text] [Related]
57. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582 [TBL] [Abstract][Full Text] [Related]
58. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369 [TBL] [Abstract][Full Text] [Related]
59. Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta. Song SY; Kim S; Kim DS; Son HJ; Rhee JC; Kim YI J Clin Gastroenterol; 2004 Mar; 38(3):252-9. PubMed ID: 15128072 [TBL] [Abstract][Full Text] [Related]
60. Frequent loss of membranous E-cadherin in gastric cancers: A cross-talk with Wnt in determining the fate of beta-catenin. Cheng XX; Wang ZC; Chen XY; Sun Y; Kong QY; Liu J; Gao X; Guan HW; Li H Clin Exp Metastasis; 2005; 22(1):85-93. PubMed ID: 16132582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]